Annual CFO
-$45.37 M
-$3.72 M-8.93%
December 31, 2021
Summary
- As of February 10, 2025, GNCA annual cash flow from operations is -$45.37 million, with the most recent change of -$3.72 million (-8.93%) on December 31, 2021.
- During the last 3 years, GNCA annual CFO has fallen by -$4.13 million (-10.03%).
Performance
GNCA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$15.21 M
-$4.10 M-36.96%
March 31, 2022
Summary
- As of February 10, 2025, GNCA quarterly cash flow from operations is -$15.21 million, with the most recent change of -$4.10 million (-36.96%) on March 31, 2022.
- Over the past year, GNCA quarterly CFO has dropped by -$2.82 million (-22.72%).
Performance
GNCA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$48.19 M
-$2.82 M-6.21%
March 31, 2022
Summary
- As of February 10, 2025, GNCA TTM cash flow from operations is -$48.19 million, with the most recent change of -$2.82 million (-6.21%) on March 31, 2022.
- Over the past year, GNCA TTM CFO has dropped by -$7.94 million (-19.72%).
Performance
GNCA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GNCA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.9% | -22.7% | -19.7% |
| 3 y3 years | -10.0% | -47.7% | -27.7% |
| 5 y5 years | +4.7% | -3.8% | -27.7% |
GNCA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +37.0% | at low | +6.2% | at low |
| 5 y | 5-year | +20.2% | at low | +83.3% | at low | +27.7% | at low |
| alltime | all time | +257.8% | +4.9% | +285.8% | at low | +852.7% | +6.2% |
Genocea Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$15.21 M(+37.0%) | -$48.19 M(+6.2%) |
| Dec 2021 | -$45.37 M(+8.9%) | -$11.11 M(-2.2%) | -$45.37 M(+3.3%) |
| Sep 2021 | - | -$11.36 M(+8.1%) | -$43.91 M(+7.5%) |
| Jun 2021 | - | -$10.51 M(-15.2%) | -$40.84 M(+1.5%) |
| Mar 2021 | - | -$12.39 M(+28.5%) | -$40.25 M(-3.4%) |
| Dec 2020 | -$41.65 M(+10.4%) | -$9.64 M(+16.2%) | -$41.65 M(+1.6%) |
| Sep 2020 | - | -$8.30 M(-16.3%) | -$40.99 M(-5.8%) |
| Jun 2020 | - | -$9.92 M(-28.1%) | -$43.50 M(+5.5%) |
| Mar 2020 | - | -$13.80 M(+53.5%) | -$41.23 M(+9.3%) |
| Dec 2019 | -$37.73 M(-8.5%) | -$8.99 M(-16.8%) | -$37.73 M(+2.2%) |
| Sep 2019 | - | -$10.81 M(+41.4%) | -$36.93 M(+3.1%) |
| Jun 2019 | - | -$7.64 M(-25.8%) | -$35.80 M(-6.8%) |
| Mar 2019 | - | -$10.30 M(+25.9%) | -$38.40 M(-6.9%) |
| Dec 2018 | -$41.23 M(-13.4%) | -$8.18 M(-15.5%) | -$41.23 M(+0.0%) |
| Sep 2018 | - | -$9.68 M(-5.5%) | -$41.23 M(-4.1%) |
| Jun 2018 | - | -$10.24 M(-22.0%) | -$42.97 M(-6.7%) |
| Mar 2018 | - | -$13.13 M(+60.7%) | -$46.07 M(-3.2%) |
| Dec 2017 | -$47.60 M | -$8.17 M(-28.5%) | -$47.60 M(-7.0%) |
| Sep 2017 | - | -$11.43 M(-14.4%) | -$51.16 M(+2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$13.34 M(-9.0%) | -$49.98 M(+7.9%) |
| Mar 2017 | - | -$14.66 M(+24.9%) | -$46.31 M(+10.7%) |
| Dec 2016 | -$41.84 M(+9.1%) | -$11.73 M(+14.5%) | -$41.84 M(+4.4%) |
| Sep 2016 | - | -$10.25 M(+5.9%) | -$40.09 M(+5.1%) |
| Jun 2016 | - | -$9.68 M(-4.9%) | -$38.14 M(+0.9%) |
| Mar 2016 | - | -$10.18 M(+1.9%) | -$37.79 M(-1.5%) |
| Dec 2015 | -$38.36 M(+39.0%) | -$9.99 M(+20.3%) | -$38.36 M(+4.3%) |
| Sep 2015 | - | -$8.30 M(-11.0%) | -$36.78 M(+6.0%) |
| Jun 2015 | - | -$9.33 M(-13.2%) | -$34.71 M(+9.1%) |
| Mar 2015 | - | -$10.75 M(+27.8%) | -$31.82 M(+15.3%) |
| Dec 2014 | -$27.60 M(+38.9%) | -$8.41 M(+35.1%) | -$27.60 M(+7.8%) |
| Sep 2014 | - | -$6.22 M(-3.2%) | -$25.60 M(+9.8%) |
| Jun 2014 | - | -$6.43 M(-1.5%) | -$23.31 M(+9.2%) |
| Mar 2014 | - | -$6.53 M(+2.0%) | -$21.35 M(+7.4%) |
| Dec 2013 | -$19.87 M(+56.7%) | -$6.40 M(+62.5%) | -$19.87 M(+47.5%) |
| Sep 2013 | - | -$3.94 M(-11.8%) | -$13.47 M(+41.4%) |
| Jun 2013 | - | -$4.47 M(-11.6%) | -$9.53 M(+88.4%) |
| Mar 2013 | - | -$5.06 M | -$5.06 M |
| Dec 2012 | -$12.68 M(-6.0%) | - | - |
| Dec 2011 | -$13.49 M | - | - |
FAQ
- What is Genocea Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Genocea Biosciences?
- What is Genocea Biosciences annual CFO year-on-year change?
- What is Genocea Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Genocea Biosciences?
- What is Genocea Biosciences quarterly CFO year-on-year change?
- What is Genocea Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Genocea Biosciences?
- What is Genocea Biosciences TTM CFO year-on-year change?
What is Genocea Biosciences annual cash flow from operations?
The current annual CFO of GNCA is -$45.37 M
What is the all time high annual CFO for Genocea Biosciences?
Genocea Biosciences all-time high annual cash flow from operations is -$12.68 M
What is Genocea Biosciences annual CFO year-on-year change?
Over the past year, GNCA annual cash flow from operations has changed by -$3.72 M (-8.93%)
What is Genocea Biosciences quarterly cash flow from operations?
The current quarterly CFO of GNCA is -$15.21 M
What is the all time high quarterly CFO for Genocea Biosciences?
Genocea Biosciences all-time high quarterly cash flow from operations is -$3.94 M
What is Genocea Biosciences quarterly CFO year-on-year change?
Over the past year, GNCA quarterly cash flow from operations has changed by -$2.82 M (-22.72%)
What is Genocea Biosciences TTM cash flow from operations?
The current TTM CFO of GNCA is -$48.19 M
What is the all time high TTM CFO for Genocea Biosciences?
Genocea Biosciences all-time high TTM cash flow from operations is -$5.06 M
What is Genocea Biosciences TTM CFO year-on-year change?
Over the past year, GNCA TTM cash flow from operations has changed by -$7.94 M (-19.72%)